Parfex creates fragrances principally for premium personal care and fine perfumery markets, leveraging the natural raw materials that are available in the region
The agreement pairs Croda’s global footprint and “smart science” approach with Amino’s precision manufacturing capabilities
Paul Waterman will step down as CEO and retire from the Board on 29 April 2025
Croda’s extensive library of natural compounds and manufacturing capabilities will help Moa develop breakthrough solutions with even greater speed and accuracy
This new facility is a key achievement in the company’s 2025 strategy to potentiate its activity in high-growth markets
This acquisition will significantly strengthen Croda’s Beauty Actives portfolio and increases its exposure to targeted prestige segments
The investment is part of Croda’s continuing commitment to develop high performance pharmaceutical ingredients and technologies for life sciences.
This new collaboration is funded through an ESPRC Prosperity Partnership and brings together experts from industry and academia to undertake new research, combining this with Croda’s unrivalled understanding of product performance and market requirements
These announcements are in line with Croda Pharma’s strategy to “Empower Biologics Delivery” and follows news on investments, earlier this year, to expand Croda Pharma’s global manufacturing capabilities to enable the next generation vaccines and therapeutic drugs.
The new facility will increase Croda’s capacity to serve rising regional consumption of its Consumer Care products and growing opportunities in Pharma and Crop Care to provide advanced and sustainable solutions to its customers
Subscribe to our newsletter & stay updated.
